Ticker: GSK CUSIP: 37733W204 Class: SPONSORED ADR
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 6,252,723 | $309,318 | — | — |
| Q3 2025 | 6,621,951 | $288,713 | — | — |
| Q2 2025 | 6,714,223 | $260,787 | — | — |
| Q1 2025 | 6,972,998 | $272,942 | — | — |
| Q4 2024 | 7,025,093 | $240,319 | — | — |
| Q3 2024 | 6,777,921 | $279,725 | — | — |
| Q2 2024 | 6,802,280 | $264,463 | — | — |
| Q1 2024 | 6,958,951 | $301,173 | — | — |
| Q4 2023 | 7,052,990 | $263,820 | — | — |
| Q3 2023 | 7,058,039 | $258,457 | — | — |
| Q2 2023 | 7,244,693 | $260,764 | — | — |
| Q1 2023 | 7,430,513 | $266,908 | — | — |
| Q4 2022 | 7,421,340 | $263,169 | — | — |
| Q3 2022 | 7,566,561 | $225,486 | — | — |